AstraZeneca and Catalent defend Covid vaccine manufacturing process

AstraZeneca and Catalent defend Covid vaccine manufacturing process

Pharma giant and key supplier say ‘every batch’ is made to same standards following EMA blood clot inquiry

AstraZeneca Vaccine Concerns Grow

AstraZeneca Vaccine Concerns Grow

“Nobody at the moment thinks that this is caused by the vaccine, but they wanted to be very cautious.” University of Auckland’s Helen Petousis-Harris answers key questions about AstraZeneca’s Covid-19 vaccine as more countries limit its use over blood clot c…